Brian Goff
Board Member
Intellia Therapeutics, Inc. (NTLA)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Brian Goff
Brian Goff is recorded as Board Member at Intellia Therapeutics, Inc. (NTLA). Intellia Therapeutics, Inc. reported in an 8-K filed June 14, 2024 that Brian Goff was appointed Class I director, effective June 13, 2024.
“On June 12, 2024, upon the recommendation of the Nominating and Corporate Governance Committee of the Board of Directors (the “Board”) of Intellia Therapeutics, Inc. (the “Company”), the Board appointed Brian Goff, as a Class I director, effective as of June 13, 2024, with a term expiring at the 2026 annual meeting of stockholders.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2024-06-13–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Intellia Therapeutics, Inc.
Other people whose current roles at this company are on record from its filings.
- Edward J. Dulac III CFO
- Andrew D. Schiermeier COO
- James Basta General Counsel
- Michael P. Dube Chief Accounting Officer
- Bill Chase Board Member
- Georgia Keresty Board Member
- Georgia Keresty, Ph.D., M.P.H. Board Member
- John M. Leonard Board Member
- John M. Leonard, M.D. Board Member
- Muna Bhanji Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.